Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More

Published 23/06/2022, 17:29
© Reuters.  44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
IXIC
-
REVRQ
-

Gainers

  • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
  • F-star Therapeutics, Inc. (NASDAQ: FSTX) shares jumped 58% to $6.28 after Sino Biopharmaceutical's invoX Pharma announced it will acquire the company for $7.12 per share. The acquisition values F-star at approximately $161 million.
  • Shift Technologies, Inc. (NASDAQ: SFT) gained 44% to $1.0200.
  • Smart for Life, Inc. (NASDAQ: SMFL) jumped 42% to $0.63. Smart for Life's Doctors Scientific Organica division has accelerated production of Milk Dust to increase milk supply, nourish the postpartum body, and help combat sugar cravings.
  • Phoenix Motor Inc. (NASDAQ: PEV) gained 37.4% to $8.01. Phoenix Motor recently reported closing of $15,750,000 initial public offering.
  • Vroom, Inc. (NASDAQ: VRM) gained 25.4% to $1.4850.
  • Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) surged 25.3% to $4.26.
  • Valneva SE (NASDAQ: VALN) shares jumped 25% to $31.07. Valneva received positive CHMP opinion for marketing authorization of its inactivated Covid-19 vaccine candidate in Europe.
  • BioSig Technologies, Inc. (NASDAQ: BSGM) surged 23.7% to $1.0891.
  • Rain Therapeutics Inc. (NASDAQ: RAIN) jumped 22.8% to $3.18. JonesTrading initiated coverage on Rain Therapeutics with a Buy rating and announced a price target of $17.
  • MSP Recovery, Inc. (NASDAQ: MSPR) gained 20% to $2.2673.
  • Kintara Therapeutics, Inc. (NASDAQ: KTRA) surged 19.1% to $0.30. The FDA recently granted Fast Track Designation to the company’s VAL-083.
  • CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) gained 17.8% to $0.3301 after the company received FDA approval for a protocol amendment to its ongoing study evaluating Berubicin in recurrent glioblastoma multiforme.
  • ATIF Holdings Limited (NASDAQ: ATIF) jumped 17.7% to $2.32.
  • RedHill Biopharma Ltd. (NASDAQ: RDHL) rose 17.4% to $0.8995 after the company reported its Q1 earnings results.
  • NextPlay Technologies, Inc. (NASDAQ: NXTP) rose 16% to $0.3085. NextPlay Technologies recently reported FY22 revenue of $8.2 million.
  • Heliogen, Inc. (NYSE: HLGN) gained 15.9% to $3.64.
  • ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 15.8% to $1.5991. ToughBuilt Industries reported the closing of $6 million public offering.
  • Nutriband Inc. (NASDAQ: NTRB) jumped 15.6% to $3.25.
  • Jiuzi Holdings, Inc. (NASDAQ: JZXN) gained 14.3% to $1.1314. Jiuzi will announce entry into an electric vehicle purchase agreement with authorized agent of WM Motor Technology Co., Ltd.
  • Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) surged 13.8% to $1.24.
  • Enjoy Technology, Inc. (NASDAQ: ENJY) rose 13.7% to $0.29 after gaining more than 5% on Wednesday.
  • ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) gained 13.6% to $0.52.
  • Motorsport Games Inc. (NASDAQ: MSGM) surged 12.8% to $0.6397.
  • ChromaDex Corporation (NASDAQ: CDXC) jumped 11.3% to $2.16.
  • GeoVax Labs, Inc. (NASDAQ: GOVX) rose 8.4% to $1.42. GeoVax Labs recently announced the appointment of John W. Sharkey, PhD to serve as Vice President, Business Development.

Losers

  • BIT Mining Limited (NASDAQ: BTCM) shares dipped 40.4% to $0.7089 after the company announced a $16 million registered direct offering.
  • Applied Therapeutics, Inc. (NASDAQ: APLT) fell 25.4% to $0.7981 as the company reported pricing of $30 million public offering of common stock and warrants.
  • Grove Collaborative Holdings, Inc. (NYSE: GROV) shares tumbled 19.7% to $6.16. Grove Collaborative Holdings’ 10% owner Richard Sir Branson recently acquired a total of 19,394,024 shares at an average price of $10.00.
  • IperionX Limited (NASDAQ: IPX) fell 18.2% to $6.46.
  • Revlon, Inc. (NYSE: REV) fell 17% to $6.76 on continued volatility following the company's recent bankruptcy filing.
  • Actelis Networks, Inc. (NASDAQ: ASNS) dropped 15.3% to $1.60. Actelis Networks recently posted a Q1 loss of $2.26 per share.
  • JX Luxventure Limited (NASDAQ: LLL) fell 14.4% to $1.49. JX Luxventure shares jumped around 17% on Wednesday after the company announced a $5 million share repurchase program and signed a $30 million sales agreement.
  • bluebird bio, Inc. (NASDAQ: BLUE) declined 13.2% to $3.87.
  • AeroClean Technologies, Inc. (NASDAQ: AERC) fell 12.2% to $13.00.
  • cbdMD, Inc. (NYSE: YCBD) dropped 11.7% to $0.4560.
  • Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) fell 10.6% to $1.0900. Rigel Pharmaceuticals recently announced data from the FORWARD Phase 3 clinical trial of Fostamatinib did not demonstrate statistical significance in the primary efficacy endpoint.
  • National CineMedia, Inc. (NASDAQ: NCMI) dipped 10.5% to $0.9298.
  • Century Aluminum Company (NASDAQ: CENX) fell 10.1% to $7.68. BMO Capital maintained Century Aluminum with a Market Perform and lowered the price target from $14 to $9.
  • Deutsche Bank (ETR:DBKGn) Aktiengesellschaft (NYSE: DB) declined 10.1% to $9.19.
  • Exela Technologies, Inc. (NASDAQ: XELA) dropped 9.9% to $0.1710. Exela Technologies recently announced a new customer win of $136 million in total contract value
  • Advent Technologies Holdings, Inc. (NASDAQ: ADN) dipped 9.6% to $2.93.
  • Green Giant Inc. (NASDAQ: GGE) fell 8.6% to $1.2892.
  • U.S. Well Services, Inc. (NASDAQ: USWS) dropped 8.3% to $0.9020. ProFrac announced it will acquire the company for approximately $1.21 per share in an all-stock deal.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.